Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants

Vaccine

Volumn 28, Issue 38, 2010, Pages 6125-6127

  Lobato, Francisco C F ^a   Lima, Catarina G R D ^a   Assis, Ronnie A ^b   Pires, Prhiscylla S ^a   Silva, Rodrigo O S ^a   Salvarani, Felipe M ^a   Carmo, Anderson O ^a   Contigli, Christiane ^c   Kalapothakis, Evanguedes ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Nacional Agricultural Laboratory of Minas Gerais   (Brazil)

^c Eduardo de Menezes Hospital   (Brazil)

Author keywords

Clostridium perfringens; Enterotoxemia; Vaccine

Indexed keywords

CLOSTRIDIUM PERFRINGENS D EPSILON TOXOID VACCINE; ENTEROTOXIN; RECOMBINANT VACCINE; TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; CATTLE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DRUG POTENCY; ENTEROTOXEMIA; ESCHERICHIA COLI; ETX GENE; GOAT; IMMUNOGENICITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RABBIT; SHEEP; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; BACTERIAL TOXINS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; ENTEROTOXEMIA; ESCHERICHIA COLI; GOAT DISEASES; GOATS; RABBITS; RECOMBINANT PROTEINS; SHEEP; SHEEP DISEASES;

EID: 77955656147     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.046     Document Type: Article

References (15)

1. Uzal F.A., Songer G. Diagnosis of Clostridium perfringens intestinal infection in sheeps and goats. J Vet Diagn Invest 2008, 20:253-265.
2. Gonçalves L.A., Lobato Z.I.P., Silva R.O.S., Salvarani F.M., Pires P.S., Assis R.A., et al. Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test. Arch Microbiol 2009, 191:847-851.
3. Lobato F.C.F., Moro E., Umehara O. Avaliação da resposta de antitoxinas beta e épsilon de Clostridium perfringens induzidas em bovinos e coelhos por seis vacinas camerciais no Brasil. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 2000, 52(4):313-318.
4. Eklund M.W., Poysky F.T., Mseitif L.M., Strom M.S. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G. Appl Environ Microbiol 1988, 54:1405-1408.
5. Pivinick H., Habeeb A.F.S.A., Gorenstein B. Effect of pH on toxigenesis by C. perfringens type C. Can J Microbiol 1965, 10(3):329-344.
6. Azevedo E.O., Lobato F.C.F., Abreu V.L.V., Maia J.D., Nascimento R.A.P. Avaliação de vacinas contra o Clostridium perfringens do tipo C e D. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 1998, 50:239-242.
7. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteiophage T4. Nature 1970, 227:680-686.
8. Sousa A.M., Reis J.K.P., Assis R.A., Siqueira F.F., Horta C.C., Facchin S., et al. Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization. Genet Mol Res 2010, 9:266-276.
9. Sebald M., Petit J.C. Laboratory methods anaerobic bacteria and their identification 1997, Institut Pasteur, Paris.
10. Reed R.H., Muench H. A single method of estimating fifty percent end points. Am J Hyg 1938, 27:493-497.
11. Brasil. Ministério da Agricultura. Portaria n. 49 12 de maio de 1997, Diário Oficial da União, Brasília.
12. European Pharmacopoeia 1998, Maisonneuve S.A., Saint Ruffine. 3 ed.
13. Uzal F.A., Kelly W.R. Protection of goats against experimental enterotoxaemia by vaccination with Clostridium perfringens type D epsilon toxoid. Vet Rec 1998, 142:722-725.
14. Goswami P.P., Rupa P., Prihar N.S., Garg L.C. Molecular cloning of Clostridium perfringens epsilon-toxin gene and its high level expression in E. coli. Biochem Biophys Res Commun 1996, 226:735-740.
15. Oyston P.C.F., Payne D.W., Havard H.L., Wiliamson E.D., Titball R.W. Production of a non-toxic site-directed mutant of Clostridium perfringens épsilon toxin which induces protective immunity in mice. Microbiology 1998, 144:333-341.